Trump Administration Approves $2.8 Billion Sale of 40,000 Bombs to Israel

Early in September 2026, reports emerged that the Trump administration was planning a large-scale arms sale to Israel. The proposed deal was valued at $2.8 billion and centered on the transfer of tens of thousands of heavy bombs.

Sources cited by several outlets described the munitions as some of the most destructive in Western military arsenals. The scale of the package marked it as one of the largest such transfers in recent years.

On September 15, 2026, initial stories revealed that the deal would include 2,000-pound bombs, with the total package reaching 40,000 units. The funding was reported to come from U.S. taxpayer money through Foreign Military Financing.

Further details published the same day clarified the bomb types: 20,000 MK-84s, 20,000 BLU-117s, and 20,000 I-2000 penetrator warheads. These are among the most powerful conventional bombs used by Western militaries.

By September 16, more outlets confirmed the approval, noting that the arms deal coincided with ongoing conflict in Gaza. Some reports highlighted international criticism and fears of mass casualties if such weapons were used in civilian areas.

According to more recent coverage, the Biden administration responded to the controversy by pausing aspects of the deal, citing humanitarian concerns as fighting in Gaza continued. The deal remains under scrutiny, with no final resolution announced.

As of mid-September 2026, the Trump administration's approval of the $2.8 billion arms deal is official, but the future of the delivery is uncertain. The Biden administration has paused parts of the transfer in response to concerns about civilian harm in ongoing conflicts involving Israel.

The deal is now subject to further review, and its implementation will depend on political and humanitarian considerations in the coming weeks.

Key questions remain about whether the full delivery of these munitions will proceed or face additional delays. The U.S. administration is under pressure from both supporters of Israel and critics worried about civilian casualties. The outcome will likely depend on developments in the Gaza conflict and ongoing political debate in Washington.